dc.contributor.author
Seika, Philippa
dc.contributor.author
Biebl, Matthias
dc.contributor.author
Raakow, Jonas
dc.contributor.author
Berndt, Nadja
dc.contributor.author
Feldbrügge, Linda
dc.contributor.author
Maurer, Max Magnus
dc.contributor.author
Dobrindt, Eva
dc.contributor.author
Thuss-Patience, Peter
dc.contributor.author
Pratschke, Johann
dc.contributor.author
Denecke, Christian
dc.date.accessioned
2023-05-05T12:01:27Z
dc.date.available
2023-05-05T12:01:27Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/39268
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-38986
dc.description.abstract
(1) Background: Endoscopic vacuum therapy (EVT) has become the mainstay in the treatment of early anastomotic leakage (AL) after esophageal resection. The effect of nRCT on the efficacy of EVT is currently unknown.
(2) Methods: Data of 427 consecutive patients undergoing minimally invasive esophagectomy between 2013 and 2022 were analyzed. A total of 26 patients received EVT for AL after esophagectomy between 2010 and 2021. We compared a cohort of 13 patients after treatment with EVT for anastomotic leakage after neoadjuvant radiochemotherapy (nRCT) with a control group of 13 patients after neoadjuvant chemotherapy (nCT) using inverse propensity score weighting to adjust for baseline characteristics between the groups. EVT therapy was assessed regarding patient survival, treatment failure as defined by a change in treatment to stent/operation, duration of treatment, and secondary complications. Statistical analysis was performed using linear regression analysis.
(3) Results: Time to EVT after initial tumor resection did not vary between the groups. The duration of EVT was longer in patients after nRCT (14.69 days vs. 20.85 days, p = 0.002) with significantly more interventions (4.38 vs. 6.85, p = 0.001). The success rate of EVT did not differ between the two groups (nCT n = 8 (61.54%) vs. nCT n = 5 (38.46%), p = 0.628). The rate of operative revision did not vary between the groups. Importantly, no mortality was reported within 30 days and 90 days in both groups.
(4) Conclusions: EVT is a valuable tool for the management of AL after esophageal resection in patients after nRCT. While the success rates were comparable, EVT was associated with a significantly longer treatment duration. Anastomotic leakages after nRCT often require prolonged and multimodal treatment strategies while innovative strategies such as prophylactic endoVAC placement or use of a VAC-Stent may be considered.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
esophageal surgery
en
dc.subject
endoscopic vacuum therapy (EVT)
en
dc.subject
anastomotic leakage
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
The Association between Neoadjuvant Radio-Chemotherapy and Prolonged Healing of Anastomotic Leakage after Esophageal Resection Treated with EndoVAC Therapy
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
4773
dcterms.bibliographicCitation.doi
10.3390/jcm11164773
dcterms.bibliographicCitation.journaltitle
Journal of Clinical Medicine
dcterms.bibliographicCitation.number
16
dcterms.bibliographicCitation.originalpublishername
MDPI
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36013012
dcterms.isPartOf.eissn
2077-0383